Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Justinian Lane

Justinian Lane Justinian C. Lane is a personal injury attorney who focuses his practice on helping individuals injured by prescription drugs and medical devices. His practice is nationwide and he welcomes e-mails at justinian@dangerousdrugs.us. His full biography is here.

Posts by Justinian Lane

Coarctation of the Aorta

Posted in Paxil Birth Defects

Coarctation of the aorta (CoA) is a heart defect present at birth characterized by “the narrowing of the major artery (the aorta) that carries blood to the body.”[1]  The American Heart Association states that “This narrowing affects blood flow where the arteries branch out to carry blood along separate vessels to the upper and lower… Continue Reading

Transposition of the Great Arteries

Posted in Paxil Birth Defects, Prozac Birth Defects, Zoloft Birth Defects

Transposition of the Great Arteries is a congenital (present at birth) heart defect found to be associated with maternal use of Prozac® during pregnancy by medical researcher Diav-Citrin in a 2008 study titled “Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study,” published in the British Journal of Clinical Pharmacology. Concerning persons suffering… Continue Reading

Tricuspid Atresia

Posted in Misc. Drugs, Paxil Birth Defects

Tricuspid atresia is a congenital (from birth) heart defect recently linked to maternal use of Paxil® during pregnancy.[1]  Paxil® is a selective serotonin-reuptake inhibitor (SSRI), a new type of antidepressant drug that helps regulate serotonin levels in the brain, a chemical involved in mood regulation. In children born with tricuspid atresia, “the tricuspid heart valve… Continue Reading

Hypoplastic Left Heart Syndrome

Posted in Misc. Drugs, Paxil Birth Defects

Hypoplastic Left Heart Syndrome (HLHS) has recently been linked with maternal use of SSRI drugs, especially Paxil®, during pregnancy.  Hypo-, from Greek meaning “less than normal, deficient”[1], and plastic, meaning “forming; growing; changing; developing”[2], hypoplastic left heart syndrome is a birth defect characterized by the underdevelopment of the left heart. This ailment results in the… Continue Reading

SSRI Use during Pregnancy Raises Risk of Serious Birth Defects

Posted in Generic Drugs, Paxil Birth Defects, Prozac Birth Defects, Zoloft Birth Defects

In a study published in a 2007 edition of the New England Journal of Medicine, Sura Alwan et al. evaluates the effect of maternal use of selective serotonin reuptake inhibitor medications (SSRIs) during pregnancy on the likelihood of bearing children with congenital malformations.  The study, titled “Use of Selective Serotonin Reuptake Inhibitors in Pregnancy and the… Continue Reading

WebMD – Mothers Who Switch SSRIs During Pregnancy Place Newborns at Risk of Heart Defects

Posted in Misc. Drugs, Paxil Birth Defects, Zoloft Birth Defects

It has been recently found that babies of mothers who filled prescriptions for more than one SSRI during pregnancy were four times as likely to be born with septal heart defects as were other babies born to mothers who did not use SSRIs during pregnancy.  If uncorrected, this birth defect, characterized by a malformation of… Continue Reading

Aortic Stenosis

Posted in Misc. Drugs, Zoloft Birth Defects

A birth defect recently found to be associated with maternal use of SSRI drugs during pregnancy,[1] aortic stenosis is characterized by the aortic valve failing to open fully, decreasing blood flow from the heart[2] through the aorta, “the main artery carrying blood out of the heart.”[3]  Specifically, aortic stenosis has been found to be connected… Continue Reading

Maternal Use of SSRIs Late in Pregnancy May Cause PPHN

Posted in Misc. Drugs, Paxil Birth Defects, Zoloft Birth Defects

A recent study published in the New England Journal of Medicine shows that infants born to mothers who used selective serotonin-reuptake inhibitors (SSRIs, a type of antidepressant medication) late in pregnancy were placed at increased risk of serious birth defects, such as persistent pulmonary hypertension (PPHN). First, some background on PPHN.  One way to explain… Continue Reading

SSRI Birth Defect – Gastroschisis

Posted in Paxil Birth Defects

Gastroschisis is a congenital (from birth) malformation “in which an infant’s intestines stick out of the body through a defect on one side of the umbilical cord.”[1]  Since at least 2007, maternal use of paroxetine (Paxil®) during pregnancy has been associated with a 2.9-fold increased risk of gastroschisis. PubMed Health, a service of the U.S…. Continue Reading

The Nurse Practitioner Warns of Increased Risk of Blood Clot with Drospirenone Use

Posted in Yaz, Yasmin & Ocella

In the “Medication Update” section of a 2011 edition of the medical journal The Nurse Practitioner, a warning regarding the use of drospirenone-containing oral contraceptives is made.  Oral contraceptives containing drospirenone are YAZ®, Beyaz®, Safyal®, and Yazmin®. The warning reads as follows: “The FDA notified healthcare providers and patients that two newly published studies evaluating… Continue Reading

Drospirenone-Containing Contraceptives Implicated as Causal Factor in Heart Attack of Young Woman

Posted in Yaz, Yasmin & Ocella

A 2010 report by the medical journal Reactions describes the case of a 20-year-old woman, otherwise in good health, who suffered a heart attack while taking an oral contraceptive containing the chemical drospirenone, found in contraceptives such as YAZ®. The case of this woman, holding no risk factors for blood clot or heart attack other… Continue Reading

Welcome to the new Dangerous Drugs

Posted in DangerousDrugs.US

Ladies and gentlemen, welcome to the new Dangerous Drugs blog.  I’m excited to have a new site with a fresh look.  I have a variety of content that will be coming in the next couple of weeks, including information about Granuflo lawsuits and settlements.  As always, if you have any questions or comments regarding prescription… Continue Reading

2009 – Study Names Chemical in YAZ® More Dangerous than Other Hormonal Contraceptives

Posted in Yaz, Yasmin & Ocella

An article published in 2009 in the British Medical Journal by Dr. A. van Hylckama Vlieg (et al.) analyzes the risk of developing a blood clot for women using hormonal contraceptives (versus non-users) and evaluates the relative risk for developing a blood clot between different types of hormonal contraceptives used today, naming the active chemical… Continue Reading

American Journal of Nursing Shows Oral Contraceptives Containing Drospirenone are More Dangerous than Others

Posted in Yaz, Yasmin & Ocella

The “Drug Watch” section of the September, 2012 edition of the American Journal of Nursing includes some startling information about hormonal contraceptive drugs containing the chemical drospirenone, such as YAZ,® Beyaz®, Safyral®, and Yasmin®. Reviewing several studies comparing the relative risks of developing a blood clot for women using drospirenone-containing hormonal contraceptives versus women using… Continue Reading

Study Evaluates Relative Risks of Hormonal Contraceptives, Names Yaz® as Particularly Dangerous

Posted in Yaz, Yasmin & Ocella

A study published in May, 2009 by the British Medical Journal notes that women using hormonal contraceptives containing drospirenone, such as Yaz®, are about 64% more likely to develop blood clots than the average woman using hormonal contraceptives.[1]  Blood clots pose a very serious risk to health, as they may cause heart attack or stroke…. Continue Reading

Case Report Names Drospirenone-Containing Hormonal Contraceptive as “Only Associated Risk Factor” in Development of Blood Clot

Posted in Yaz, Yasmin & Ocella

A report published in 2006 in the medical journal Clinical and Applied Thombosis/Hemostasis reviews the case of a woman, aged 36 years, who came under the care of Dr. Y. Mira, presenting deep venous thromboses (blood clots) in the “left jugular and subclavian” veins.[1]  Blood clots are a very serious occurrence, possibly leading to heart… Continue Reading

Study Shows YAZ Places Users at Higher Risk of Hyperkalemia

Posted in Yaz, Yasmin & Ocella

A recent study published in the journal BioMedCentral Pharmacology aimed to evaluate potential health risks posed to users of hormonal contraceptives containing drospirenone, such as YAZ®. In this report, titled “The association between drospirenone and hyperkalemia: a comparative-safety study” a team of researchers led by Dr. ST Bird studied 1,148,183 women, and found that users of drospirenone-containing… Continue Reading

Washington State Actos Cases

Posted in Actos & Bladder Cancer

If anyone in Washington is looking for help with a potential Actos bladder cancer case, give me a call.  I have an office in Redmond and am accepting cases from people all across the state, including as far away as Spokane and as close as Bellevue.  I am happy to help anyone who is looking… Continue Reading

I’m Now Able to Help Individuals Who Developed Bladder Cancer While Taking Actos

Posted in Actos & Bladder Cancer

About a year ago I wrote a quick blog post about whether Actos causes bladder cancer.  At the time, I wasn’t certain whether there was enough evidence to support filing an Actos bladder cancer lawsuit. I’m now convinced that there is credible medical evidence that shows that Actos causes bladder cancer.  I’m therefore accepting cases… Continue Reading